Case Study

Leveraging ADVASEPT® Technology

Format: PDF file | Document type: Case Study | Promoted Content

This content is provided by Catalent, and any views and opinions expressed do not necessarily reflect those of

Leveraging ADVASEPT® Technology

Catalent’s ADVASEPT®​ Technology is an advanced aseptic manufacturing process that leverages blow-fill-seal (BFS) technology to create a glass free container closure that drastically reduces the risk of foreign particulates and microbial contamination. This technology allows the freedom to create a new primary container that meets the needs required for global vaccine distribution. BFS has been used for over 20 years for commercial biologic drug products and Catalent recently completed a direct comparison between a model mAb filled in glass vials and ADVASEPT® ​Vials. Learn more today.

Latest content from Catalent

Related resources from Catalent

Show more

Supplier info centre